Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xi'an Yuanda Kechuang Pharmaceutical Technology is a specialized research and development subsidiary of China Grand Pharmaceutical and Healthcare Holdings Limited. Based in Xi'an, China, the company serves as a core innovation hub focusing on the discovery and development of high-end chemical drugs and biological products. Its primary therapeutic focus areas include ophthalmology, cardiovascular diseases, and oncology, where it manages the drug development lifecycle from early-stage research through clinical trial management. The company plays a critical role in advancing the parent group's innovative pipeline, particularly through the development of novel formulations and targeted therapies for the Chinese and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xi'an Yuanda Kechuang Pharmaceutical Technology.